U-Blot® Research Grade FezakinumabCat. No. WA2860$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade FezakinumabCat. No. WA2860
U-Blot® Research Grade fetrastobartCat. No. WA2859
U-Blot® Research Grade FepixnebartCat. No. WA2858
U-Blot® Research Grade FelzartamabCat. No. WA2857
U-Blot® Research Grade FelvizumabCat. No. WA2856
U-Blot® Research Grade felmetatugCat. No. WA2855
U-Blot® Research Grade FelmetatugCat. No. WA2854
U-Blot® Research Grade felcorekibartCat. No. WA2853
U-Blot® Research Grade FeladilimabCat. No. WA2852
U-Blot® Research Grade FazpilodemabCat. No. WA2851
U-Blot® Research Grade faziprumigCat. No. WA2850
U-Blot® Research Grade FavezelimabCat. No. WA2849